WebDec 15, 2024 · Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies for HDV and other serious rare diseases. The Eiger … WebDec 15, 2024 · Eiger BioPharmaceuticals Announces Leadership Change. President and CEO David A. Cory resigns from the company effective immediately. PALO ALTO, …
Eiger BioPharmaceuticals Announced President and CEO David A. Cory …
WebApr 10, 2024 · CEO David Cory 56 Stock Exchange Ticker Symbol Full Company Profile Financial Performance In 2024, EIGR's revenue was $13.48 million, an increase of 11.05% compared to the previous year's $12.14 million. Losses were -$96.78 million, 185.3% more than in 2024. Financial Statements Analyst Forecast WebAug 8, 2024 · Eiger BioPharmaceuticals, Inc. ( NASDAQ: EIGR) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Sri Ryali - Chief Financial Officer David Cory - President and... killian hill dental care lilburn ga
Eiger BioPharmaceuticals CEO David Cory resigns, David …
WebDavid Cory - Eiger BioPharmaceuticals - President, CEO. Thanks, Paul. Everyone at Eiger shares your enthusiasm for the potential merger. I’d like to complement you and the Celladon team for your steadfast dedication to acting in the best interest of your shareholders and for the respect for Eiger that everyone at Celladon displayed during the ... WebDec 15, 2024 · President and CEO David A. Cory resigns from the company effective immediately Dr. David Apelian named Interim CEO Eiger BioPharmaceuticals, Inc. ("Eiger" or "the company") EIGR -4.55% +... WebAs President and Chief Executive Officer at EIGER BIOPHARMACEUTICALS INC, David A. Cory made $3,504,020 in total compensation. Of this total $610,171 was received as a salary, $395,966 was received as a bonus, $2,011,338 was received in stock options, $469,530 was awarded as stock and $17,015 came from other types of compensation. killian hill christian school reviews